Drug · DIN 02447711
TECHNIVIE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2018; first marketed November 24, 2015.
- Drug Identification Number (DIN)
- 02447711
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ombitasvir, paritaprevir and ritonavir J05AP53
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OMBITASVIR | 12.5 MG | |
| PARITAPREVIR | 75 MG | |
| RITONAVIR | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 20, 2015: NOC 17403New Drug Submission (NDS)